Document Detail


Steroid hormone levels during pregnancy and incidence of maternal breast cancer.
MedLine Citation:
PMID:  11927496     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous studies evaluating pregnancy hormone levels and maternal breast cancer were limited to surrogate indicators of exposure. This study directly evaluates the association between measured serum steroid hormone levels during pregnancy and maternal risk of breast cancer. A nested case-control study was conducted to examine third-trimester serum levels of total unconjugated estradiol, estrone, estriol, and progesterone in women who were pregnant between 1959 and 1966. Cases (n = 194) were diagnosed with in situ or invasive breast cancer between 1969 and 1991. Controls (n = 374) were matched to cases by age at the time of index pregnancy, using randomized recruitment. Elevated progesterone levels were associated with a decreased incidence of breast cancer [odds ratio (OR) for progesterone > or =270 ng/ml, 0.49; 95% confidence interval (CI), 0.22-1.1] relative to those below the lowest decile. This association was stronger for cancers diagnosed at or before age 50 (OR for progesterone > or =270 ng/ml, 0.3; 95% CI, 0.1-0.9). Increased estrone levels were associated with an increased incidence overall (OR for estrone > or =18.7 ng/ml, 2.5; 95% CI, 1.0-6.2), whereas a positive association with estradiol was not observed. Too few cases occurred within 15 years of the index pregnancy to compare adequately the short- and long-term effects of pregnancy hormone exposure. When estrogen-to-progesterone ratios were evaluated, there was an indication of a modest increased incidence of breast cancer for those with high total estrogens and high estrone levels relative to progesterone. These findings suggest that pregnancy steroid hormone levels are risk factors for breast cancer.
Authors:
Jennifer David Peck; Barbara S Hulka; Charles Poole; David A Savitz; Donna Baird; Barbara E Richardson
Related Documents :
17722996 - Solid cancer incidence in atomic bomb survivors: 1958-1998.
17194906 - Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
17035426 - Association between lung cancer incidence and family history of lung cancer: data from ...
9428496 - Cancer among spouses: review of 195 couples.
17131396 - Inherited aspects of papillary thyroid carcinoma.
11945186 - The cause of death in patients with head and neck squamous cell carcinoma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  11     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-04-02     Completed Date:  2002-04-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  361-8     Citation Subset:  IM    
Affiliation:
Department of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, North Carolina 27599, USA. jdpeck@srph.tamu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Breast Neoplasms / etiology*,  pathology
Case-Control Studies
Estrogens / adverse effects*,  blood*
Female
Humans
Odds Ratio
Pregnancy
Pregnancy Complications, Neoplastic / etiology*,  pathology
Progesterone / adverse effects*,  blood*
Risk Factors
Grant Support
ID/Acronym/Agency:
N01HD63258/HD/NICHD NIH HHS; R03 CA75953/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Estrogens; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of...
Next Document:  Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality,...